Details for New Drug Application (NDA): 021190
✉ Email this page to a colleague
NDA 021190 describes BUSPAR, which is a drug marketed by Bristol Myers Squibb and is included in two NDAs. Additional details are available on the BUSPAR profile page.
The generic ingredient in BUSPAR is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
The generic ingredient in BUSPAR is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
Summary for 021190
| Tradename: | BUSPAR |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | buspirone hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021190
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 20, 2000 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 20, 2000 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 20, 2000 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
